NEW YORK (GenomeWeb) – Johns Hopkins University researchers have developed a proof-of-concept platform and assay for use in the clinic to test for the hepatitis C virus. The development comes on the back of an internal study that indicated 60 percent of patients don't return to the clinic to take required confirmatory RNA testing for the hepatitis C virus.

Importantly, the system could enable testing and prescribing treatment for patients during a single office visit, Jeff Tza-Huei Wang, one of the test developers and a researcher at Johns Hopkins, said in an interview.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.